Alert / Employee Benefits
A Data-driven Approach to Predicting Specialty Pharmacy Costs

Hundreds of new specialty drugs are in the approval pipeline. Because these new drugs come with high price tags, the time to begin predicting their impact on your plan’s costs is now, before they hit the market. Two Lockton Benefit Group experts share ways employers can prepare, using a data-driven approach. Read more.

    
< Back to Insights & Publications
Discover more Insights & Publications  |  Read more in the Lockton Newsroom  |  See our Client Stories
Read more in the Lockton Newsroom
See our Client Stories